Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7469881 | 0.91 | BTN3A1 (0.61) | BTN3A1CYP3A4EPHX1ALDH1A1TSHR | |
| SCHEMBL3211428 | 0.90 | BTN3A1 (0.72) | BTN3A1CYP3A4 | |
| SCHEMBL21576839 | 0.88 | BTN3A1 (0.55) | BTN3A1CYP3A4 | |
| SCHEMBL2785820 | 0.86 | BTN3A1 (0.53) | BTN3A1 | |
| SCHEMBL3215373 | 0.85 | BTN3A1 (0.77) | BTN3A1 | |
| SCHEMBL3211424 | 0.80 | BTN3A1 (0.85) | BTN3A1 | |
| SCHEMBL17705187 | 0.79 | BTN3A1 (0.59) | BTN3A1EPHX1 | |
| SCHEMBL21571268 | 0.79 | BTN3A1 (0.77) | BTN3A1EPHX1TSHR | |
| Isopentenyl Phosphate SCHEMBL545278 | 0.79 | BTN3A1 (0.70) | BTN3A1EPHX1 | |
| SCHEMBL3215369 | 0.78 | BTN3A1 (0.81) | BTN3A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015056813-A1 | METHOD FOR PRODUCING ISOPRENE USING BACTERIUM | AJINOMOTO CO., INC. (JP) | 2015-04-23 | — | — | WO | disclosed |
| US-20100068179-A1 | Phosphohalohydrins, Process For The Production Thereof And Use Thereof | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2010-03-18 | — | — | US | disclosed |
| US-7625879-B2 | Phosphohalohydrins, process for the production thereof and use thereof | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2009-12-01 | — | — | US | disclosed |
| US-7432253-B2 | Phosphoepoxides, method for making same and uses | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2008-10-07 | — | — | US | disclosed |
| US-20060287274-A1 | Phosphoepoxides, method for making same and uses | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2006-12-21 | — | — | US | disclosed |
| US-20060287281-A1 | Phosphohalohydrins, process for the production thereof and use thereof | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2006-12-21 | — | — | US | disclosed |
| US-7109183-B2 | Phosphohalohydrins, process for the production thereof and use thereof | Institut National de la Sante et de la Recherchik Medicale (FR) | 2006-09-19 | — | — | US | disclosed |
| US-7101711-B1 | Phosphoepoxides, method for making same and uses | INSTITUT NATIONAL DE LA SANTA ET DE LA RECHERCHE MEDICALE (FR) | 2006-09-05 | — | — | US | disclosed |
| US-20040087555-A1 | Phosphohalohydrins, process for the production thereof and use thereof | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICATE (FR) | 2004-05-06 | — | — | US | disclosed |
| US-6660723-B1 | Activating primate gamma delta lymphocytes | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2003-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060287274-A1 | Phosphoepoxides, method for making same and uses | CD4, CCR9, BCL9 | BTN3A1 315/4885CYP3A4 1649/4885EPHX1 804/4885 |
| US-20040087555-A1 | Phosphohalohydrins, process for the production thereof and use thereof | CD4, HRH3, HRH1 | BTN3A1 24/4885CYP3A4 3816/4885EPHX1 2055/4885 |
| US-20060287281-A1 | Phosphohalohydrins, process for the production thereof and use thereof | CD4, CCR9, BCL9 | BTN3A1 15/4885CYP3A4 2131/4885EPHX1 1845/4885 |
| US-20100068179-A1 | Phosphohalohydrins, Process For The Production Thereof And Use Thereof | CD4, CCR9, ICOS | BTN3A1 16/4885CYP3A4 2655/4885EPHX1 1819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.